Health Care & Life Sciences » Pharmaceuticals | Sam-A Pharm. Co. Ltd.

Sam-A Pharm. Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
54,637
56,776
59,658
65,876
61,792
Cost of Goods Sold (COGS) incl. D&A
21,777
22,485
23,447
25,758
23,892
Gross Income
32,859
34,291
36,211
40,118
37,900
SG&A Expense
26,805
28,479
30,160
30,541
30,289
EBIT
6,055
5,812
6,051
9,577
7,611
Unusual Expense
-
190
142
47
177
Non Operating Income/Expense
88
177
26
53
69
Interest Expense
391
70
3
1
-
Pretax Income
8,471
8,433
8,286
11,405
9,067
Income Tax
1,284
365
1,126
1,538
3,265
Consolidated Net Income
7,187
8,068
7,160
9,867
5,802
Net Income
7,187
8,068
7,160
9,867
5,802
Net Income After Extraordinaries
7,187
8,068
7,160
9,867
5,802
Net Income Available to Common
7,187
8,068
7,160
9,867
5,802
EPS (Basic)
1,178.00
1,322.00
1,173.00
1,617.00
951.00
Basic Shares Outstanding
6
6
6
6
6
EPS (Diluted)
1,177.60
1,321.91
1,173.12
1,616.69
950.61
Diluted Shares Outstanding
6
6
6
6
6
EBITDA
8,161
7,897
8,237
11,982
10,098
Non-Operating Interest Income
2,895
2,704
2,354
1,729
1,565

About Sam-A Pharm. Co.

View Profile
Address
49 Donghwagongdan-ro
Wonju GA 26365
Korea, Republic Of
Employees -
Website http://www.samapharm.co.kr
Updated 09/14/2018
Sam-A Pharm. Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include antibiotics, antiviral, antifungal, antihistamines, dermatology, pain and inflammation, respiratory, gastrointestinal, cardiovascular, metabolism, and urological drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.